Medicare Enrolled
Dr. James Egner, MD
Hematology & Oncology · Urbana, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Egner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Egner?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Egner
Dr. James Egner is a hematology & oncology specialist in Urbana, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Egner performed 1,503 Medicare services across 352 unique beneficiaries.
Between the years covered by Open Payments, Dr. Egner received a total of $9,318 from 49 pharmaceutical and/or device companies across 507 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Egner is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 42% volume in IL
$9,318 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,503
Medicare services
Top 42% in IL for hematology & oncology
352
Unique beneficiaries
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~79 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
281 | $91 | $300 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
277 | $11 | $93 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
180 | $1 | $93 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
154 | $46 | $395 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
142 | $2 | $94 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
119 | $1 | $94 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
82 | $98 | $680 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
70 | $21 | $185 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
69 | $19 | $180 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
61 | $15 | $165 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
54 | $22 | $195 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $122 | $650 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
52.7% high complexity
23.1% medium
24.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,318
Total received (2018-2024)
Avg $1,331/year across 7 years
Top 32% in IL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
507
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,770 (83.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,547 (16.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,072
2023
$1,790
2022
$1,535
2021
$1,085
2020
$926
2019
$1,008
2018
$901
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$275
Daiichi Sankyo Inc.
$184
AstraZeneca Pharmaceuticals LP
$168
ABBVIE INC.
$159
Lilly USA, LLC
$144
PFIZER INC.
$143
Astellas Pharma US Inc
$137
Merck Sharp & Dohme LLC
$113
Gilead Sciences, Inc.
$93
Celgene Corporation
$90
ARRAY BIOPHARMA INC
$76
GENZYME CORPORATION
$75
Novartis Pharmaceuticals Corporation
$65
BeiGene USA, Inc.
$43
Eisai Inc.
$40
Genentech USA, Inc.
$38
TAIHO ONCOLOGY, INC.
$37
Adaptive Biotechnologies Corporation
$33
Mirati Therapeutics, Inc.
$31
GlaxoSmithKline, LLC.
$23
Teva Pharmaceuticals USA, Inc.
$22
Genentech, Inc.
$21
Incyte Corporation
$20
EMD Serono, Inc.
$20
E.R. Squibb & Sons, L.L.C.
$19
Top 3 companies account for 30.3% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$871
AstraZeneca Pharmaceuticals LP
$746
Janssen Biotech, Inc.
$726
Novartis Pharmaceuticals Corporation
$577
PFIZER INC.
$527
Genentech USA, Inc.
$513
Celgene Corporation
$479
GENZYME CORPORATION
$457
Daiichi Sankyo Inc.
$455
Merck Sharp & Dohme Corporation
$425
E.R. Squibb & Sons, L.L.C.
$367
Merck Sharp & Dohme LLC
$353
ABBVIE INC.
$305
Amgen Inc.
$221
Astellas Pharma US Inc
$194
Gilead Sciences, Inc.
$186
ARRAY BIOPHARMA INC
$166
Pharmacyclics LLC, An AbbVie Company
$140
Seagen Inc.
$123
Eisai Inc.
$121
AbbVie Inc.
$117
TAIHO ONCOLOGY, INC.
$102
Taiho Oncology, Inc.
$98
BeiGene USA, Inc.
$95
GlaxoSmithKline, LLC.
$87
EMD Serono, Inc.
$81
Clovis Oncology, Inc.
$68
Incyte Corporation
$58
EISAI INC.
$51
Takeda Pharmaceuticals U.S.A., Inc.
$51
Exelixis Inc.
$49
Alexion Pharmaceuticals, Inc.
$48
Genentech, Inc.
$44
Pharmacyclics LLC, an AbbVie Company
$42
AVEO Pharmaceuticals, Inc.
$40
Ipsen Biopharmaceuticals, Inc
$38
G1 Therapeutics, Inc.
$35
Adaptive Biotechnologies Corporation
$33
Mirati Therapeutics, Inc.
$31
Pharmacosmos Therapeutics Inc.
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
Karyopharm Therapeutics Inc.
$27
Teva Pharmaceuticals USA, Inc.
$22
Bayer HealthCare Pharmaceuticals Inc.
$18
Rigel Pharmaceuticals, Inc.
$18
Verastem, Inc.
$17
Puma Biotechnology, Inc.
$13
Regeneron Healthcare Solutions, Inc.
$13
Medtronic USA, Inc.
$13
Top 3 companies account for 25.2% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · AFINITOR · ALIMTA · Alecensa · Avastin · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CALQUENCE · CAPRELSA · COSELA · CREON · CYRAMZA · Cabometyx · Copiktra · DARZALEX · ELIQUIS · ELITEK · ENHERTU · EPKINLY · ERLEADA · Enhertu · Erleada · FASLODEX · FOTIVDA · GAZYVA · GILOTRIF · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · IRESSA · Imbruvica · Inrebic · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONOFERRIC · MYLOTARG · Nerlynx · Neulasta · Nplate · OJJAARA · ONGLYZA · ONUREG · OPDIVO · OPDUALAG · OSTEOCOOL RF ABLATION · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · Perjeta · Pomalyst · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SOMATULINE DEPOT · SPRYCEL · TALZENNA · TASIGNA · TECENTRIQ · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Trodelvy · Truxima · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vyloy · XALKORI · XGEVA · XPOVIO · XTANDI · Xofigo · Xospata · ZEJULA · ZYTIGA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (83%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
13
Per 100K population
6.3
County median income
$63,091
Nearest hospital
CARLE FOUNDATION HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Egner is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Egner experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Egner performed 281 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Egner receive payments from pharmaceutical companies?
Yes. Dr. Egner received a total of $9,318 from 49 companies across 507 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Egner's costs compare to other hematology & oncology specialists in Urbana?
Dr. Egner's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Egner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Urbana
Browse hematology & oncology specialists in Urbana ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in IL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in IL
Which IL hematology & oncology specialists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology